"LUCIA aims to constitute a toolbox for discovering and understanding new risk factors that contribute to lung cancer development. The toolbox encompasses the analysis of three complementary aspects that feed into each other: personal risk factors, external risk factors and the cellular processes."

"HappyMums is designed to improve understanding on the biological mechanisms underlying the development of depressive symptoms in pregnancy, and the efficacy of possible therapeutic interventions.It will interrogate a large collection of cohorts with multiple biological, medical, sociodemographic and environmental and lifestyle data to identify the most robust risk factors triggering depressive symptoms."

"RESTORE VISION is exploring new treatments for 7 rare eye diseases (REDs) of the ocular surface by developing new therapeutics, repurposing existing generic drugs, and conducting pioneering clinical trials to ensure their safety and effectiveness.
This will improve the life of patients living with RED, which represent 1.7% of the total visual impairment and blindness population in Europe."

"REDDIE aims to explore how Real-world data can complement randomized controlled trials to improve the efficacy, safety, and value for money of technologies to prevent and treat diabetes.
This will help to maximise Europe’s scientific expertise and know-how to benefit people with diabetes, resulting in safer, more efficient, and cost-effective interventions."

"SQUEEZE aim is optimising the selection of available prescription drugs based on individualized biomarkers and thereby improving the efficacy and safety of existing treatments of rheumatoid arthritis.
The project focuses on personalised care and seeks to improve patient adherence, ensuring that each patient receives the most promising and safest treatment tailored to their unique needs and preferences."

"Discovering chronic inflammation biomarkers that define key stages in the Healthy-toNASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies.
The project focuses on personalised care and seeks to improve patient adherence, ensuring that each patient receives the most promising and safest treatment tailored to their unique needs and preferences."

"The vision of T2EVOLVE is to build a sustainable innovation ecosystem that will support the development of advanced engineered T cell therapy to a level where every European cancer patient in need has access to safe and effective (curative) T cell products."

"Through cutting-edge research supported by Horizon Europe, we aim to create a transformative 'immunometer' that ensures optimal immune response, minimizing risks of infection and rejection while maximizing patient well-being."

"The SLEEP REVOLUTION project is introducing an approach based on machine learning to assess Obstructive sleep apnea (OSA) severity and treatment needs. OSA remains poorly diagnosed and ineffectively treated. Through a set of wearables and a digital management platform, the project aims to bring together researchers, patients and healthcare professionals to provide an up-to-date method of accurate OSA diagnosis amd optimal treatment."

"VAX-TRUST focused on exploring vaccine hesitancy as a widespread issue, aiming to enhance healthcare professionals' understanding and approach towards vaccine-hesitant individuals by offering them comprehensive sociological research insights."

"InnoCAR-T is a Doctoral Network advancing CAR T cell immunotherapy through cutting-edge gene editing and nanotechnology, bridging academic research with industrial practices to create next-generation treatments."

"The CHAIMELEON project aims to develop a structured repository of health images and related clinical and molecular data on the most prevalent cancers in Europe: lung, breast, prostate and colorectal."

"Developing a support system for improving the quality of life of cancer home patients by combining technologies for data and knowledge management with socio-psychological models and theories."

"ARMOR-T tests new therapeutic cells against different forms of solid cancer."

"Big Data analytics for health bio-data present excellent opportunities and encounter big challenges. The AEGLE project, following a unique user-oriented approach, overcame these difficulties and generated value from healthcare data through the development of a framework for Big Data analytics that aims to improve translational medicine, to facilitate personalised and integrated care services, and to promote data-driven research across Europe, by allowing integration with data of different types and scales, and creating advanced analytics pipeline."

"The EU-funded ODIN project, in response to the challenges faced by European hospitals during the COVID-19 pandemic, aims to address 11 key hospital care challenges by integrating robotics, IoT, and AI. This initiative focuses on easing the burden on hospital staff through the use of autonomous and collaborative robots, offering various assistance services ranging from clinical to logistical. The project's main objective is to promote data-driven procedures and management in healthcare."

"The EU's GATEKEEPER project aims to aid the aging population's independent living by linking healthcare providers, businesses, and communities, focusing on collaboration and data protection. Involving 40,000 elderly citizens and stakeholders across 7 EU member states, it seeks to foster innovative solutions for healthier, independent lives."

"The Long COVID project, coordinated by Helsinki University Hospital (HUS), aims to understand the mechanisms of LCS by combining frontline expertise from the fields of clinical medicine, virology, metabolism, and immunology."

"RISCC project results will provide evidence for policy makers to take decisions on cervical cancer screening in the EU Member States. The RISCC consortium has established close connection with patient organizations and policy makers. The project will gather evidence on risk factors of cervical precancer and on the use of testing with self-sampling kits. This will help to reduce the volume of redundant screening. The main impact will be implementation of state-of-the-art and cost-efficient cervical cancer screening."